东亚药业
(605177)
| 流通市值：24.14亿 | | | 总市值：24.37亿 |
| 流通股本：1.14亿 | | | 总股本：1.15亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 264,569,472.69 | 940,185,710.07 | 596,338,949.81 | 415,858,305.39 |
| 营业收入 | 264,569,472.69 | 940,185,710.07 | 596,338,949.81 | 415,858,305.39 |
| 二、营业总成本 | 292,086,877.75 | 1,003,397,048.89 | 657,126,527.92 | 425,107,404.13 |
| 营业成本 | 208,142,084.78 | 718,115,167.38 | 441,536,593.35 | 290,462,901.6 |
| 税金及附加 | 5,037,663.72 | 11,981,453.84 | 10,361,481.67 | 5,138,105.93 |
| 销售费用 | 3,129,858.49 | 12,765,068.45 | 9,735,338.46 | 7,077,804.56 |
| 管理费用 | 46,107,570.25 | 161,104,471.63 | 123,049,098.01 | 78,081,656.88 |
| 研发费用 | 20,820,014.51 | 86,763,471.06 | 66,233,932.09 | 42,365,947.12 |
| 财务费用 | 8,849,686 | 12,667,416.53 | 6,210,084.34 | 1,980,988.04 |
| 其中:利息费用 | 9,125,998.98 | 17,347,089.54 | 10,207,428.55 | 5,095,918.51 |
| 其中:利息收入 | 1,051,944.54 | 4,672,590.59 | 3,546,018.58 | 2,516,608.4 |
| 三、其他经营收益 | | | | |
| 加:投资收益 | 1,235,387.12 | 2,934,648.08 | 2,292,116.88 | 1,467,591.82 |
| 资产处置收益 | 13,690.53 | -387,524.12 | -12,707.18 | -4,303.49 |
| 资产减值损失(新) | -12,118,295.34 | -44,115,906.92 | -34,746,495.37 | -31,980,426.01 |
| 信用减值损失(新) | 296,366.37 | 154,066.45 | 2,611,427.45 | -43,149.17 |
| 其他收益 | 3,341,256.81 | 20,018,841.63 | 10,998,033.4 | 7,288,309.1 |
| 四、营业利润 | -34,748,999.57 | -84,607,213.7 | -79,645,202.93 | -32,521,076.49 |
| 加:营业外收入 | 60,335.51 | 1,646,014.43 | 1,066,237.83 | 187,455.29 |
| 减:营业外支出 | 586,655.97 | 5,611,948.25 | 2,824,023.4 | 1,811,629.06 |
| 五、利润总额 | -35,275,320.03 | -88,573,147.52 | -81,402,988.5 | -34,145,250.26 |
| 减:所得税费用 | -73,662.02 | -6,140,998.39 | -8,957,131.41 | -3,880,698.64 |
| 六、净利润 | -35,201,658.01 | -82,432,149.13 | -72,445,857.09 | -30,264,551.62 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | -35,201,658.01 | -82,432,149.13 | -72,445,857.09 | -30,264,551.62 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | -35,201,658.01 | -82,391,993.93 | -72,409,578.27 | -30,228,272.8 |
| 少数股东损益 | - | -40,155.2 | -36,278.82 | -36,278.82 |
| 扣除非经常损益后的净利润 | -38,636,500.22 | -94,514,505.66 | -81,984,651.67 | -35,880,868.77 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | -0.31 | -0.72 | -0.63 | -0.26 |
| (二)稀释每股收益 | -0.19 | -0.48 | -0.49 | -0.2 |
| 九、综合收益总额 | -35,201,658.01 | -82,432,149.13 | -72,445,857.09 | -30,264,551.62 |
| 归属于母公司股东的综合收益总额 | -35,201,658.01 | -82,391,993.93 | -72,409,578.27 | -30,228,272.8 |
| 归属于少数股东的综合收益总额 | - | -40,155.2 | -36,278.82 | -36,278.82 |
| 公告日期 | 2026-04-30 | 2026-04-23 | 2025-10-31 | 2025-08-29 |
| 审计意见(境内) | | 标准无保留意见 | | |